Meeting the needs for haematologists and clinical chemists for an up to date reference, this atlas provides a visual presentation of lymphoproliferative disorders, leukaemia and plasma cell neoplasms. Compiled by leading experts in the UK, each malignancy is surveyed based on molecular and cellular changes, including histochemistry, cytochemistry and relevant radiographs. Pertinent clinical information relating to clinical presentation, differential diagnosis and prognostic indicators are concisely outlined, using numerous graphics and citing key references in the field. A companion volume in the series will comprise an illustrated guide to myeloid malignancies.
BENEFITS: Provides the most up-to-date reference of its type in the field of haematology. - Assists visual investigation of signs and symptoms. - Ready to-use-information in an easily accessible format.
READERSHIP: Haematologists; Clinical scientists (cytopathology, histopathology, pathologists); Doctors in training.
1. The molecular basis of lymphoid neoplasms
2. Acute lymphoblastic leukaemia/lymphoblastic lymphoma
3. Mature/chronic lymphoproliferative disorders - B lineage
- Chronic lymphocytic leukaemia/small lymphocytic lymphoma
- Prolymphocytic leukaemia
- Follicular lymphoma
- Mantle cell lymphoma
- Lymphoplasmacytic lymphoma
- Marginal zone lymphomas (nodal, MALT and splenic including splenic lymphoma with villous lymphocytes)
- Hairy cell leukaemia
- Hairy cell leukaemia variant
- Burkitt’s lymphoma
- Diffuse large B-cell lymphoma (including mediastinal B-cell lymphoma)
- AIDS-related lymphoma
4. Mature/chronic lymphoproliferative disorders - T and NK lineages
- Adult T-cell leukaemia/lymphoma
- Sézary syndrome
- Large granular lymphocyte leukaemia/lymphoma
- T-lineage prolymphocytic leukaemia
5. Plasma cell neoplasms
- Multiple myeloma
- Monoclonal gammopathy of undetermined significance
- Less common plasma cell neoplasms (plasma cell leukaemia, heavy chain disease, AL amyloidosis)
E Matutes, Consultant Haematologist, The Royal Marsden NHS Foundation Trust and Section of Haemato-Oncology, Institute of Cancer Research, London, UK; BJ Bain, Honorary Consultant Haematologist, St Mary's Hospital NHS Trust and Dept. Haematology, Faculty of Medicine, St. Mary's Hospital Campus of Imperial College, London, UK; A Wotherspoon, Consultant Histopathologist, The Royal Marsden NHS Foundation Trust, London, UK.